av/cytodyn--big.svg

COM:CYTODYN

CytoDyn Inc.

  • Stock

0.30

+13.12%

0.03

last updated 26/07 01:40:06

Last Close

0.27

01/05 20:00

Market Cap

149.26M

Beta: -

Volume Today

2.44M

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (“COVID-19”). ...Show More